Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

25
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
25
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

5.3K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
5.3K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

2.0K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transitional initiatives for advancing the phasing out of the use of animals for drug and chemical safety testing: The IHI VICT3R project for reducing the use of animals by implementing virtual control groups.

NAM journal·2026
Same author

TOXTRUST: a tool leveraging the Dempster-Shafer Theory for robust integration of NAM results in decision-making considering uncertainty.

NAM journal·2026
Same author

PM<sub>2.5</sub> air pollution inequities in the US by sector and state: Past trajectories and future directions.

Science advances·2026
Same author

Non-invasive, home cage digital monitoring for improved safety pharmacology assessments in drug development: ICH S7A update considerations.

Journal of pharmacological and toxicological methods·2026
Same author

Integrating Genetic Variants and Expression Profiles of Pharmacogenes to Investigate Resistance to Antidepressant Treatment.

Medicina (Kaunas, Lithuania)·2026
Same author

Transforming animal study toxicology reports into structured, harmonized data using large language models.

Archives of toxicology·2026
Same journal

Exposure timing is a determinant of fine particulate matter (PM2.5) pulmonary, vascular and metabolic toxicity in male mice.

Toxicological sciences : an official journal of the Society of Toxicology·2026
Same journal

A fond farewell to Jeffrey Peters, editor-in-chief of ToxSci.

Toxicological sciences : an official journal of the Society of Toxicology·2026
Same journal

Aryl hydrocarbon Receptor Nuclear Translocator 2: A Forgotten Per-ARNT-Sim Transcription Factor.

Toxicological sciences : an official journal of the Society of Toxicology·2026
Same journal

ToxMet: a web tool for toxicogenomic data analysis using genome-scale metabolic modeling.

Toxicological sciences : an official journal of the Society of Toxicology·2026
Same journal

T-cell chromatin states reflect individual differences in ex vivo cytokine release and cytotoxicity induced by T-cell engager ERY22 in cynomolgus monkeys.

Toxicological sciences : an official journal of the Society of Toxicology·2026
Same journal

DILI-Context: A Dose- and Exposure-Enriched Knowledge Base for Translational Liver Safety Assessment.

Toxicological sciences : an official journal of the Society of Toxicology·2026
See all related articles

Related Experiment Video

Updated: Feb 18, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.7K

Generating Modeling Data From Repeat-Dose Toxicity Reports.

Oriol López-Massaguer1, Kevin Pinto-Gil1, Ferran Sanz1

  • 1Research Programme on Biomedical Informatics (GRIB), Department of Experimental and Health Sciences, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Pompeu Fabra, 08003 Barcelona, Spain.

Toxicological Sciences : an Official Journal of the Society of Toxicology
|November 21, 2017
PubMed
Summary
This summary is machine-generated.

Pharmaceutical companies compile in vivo repeat-dose toxicity (RDT) studies into a database. This work details a method to standardize and extract comparable toxicological data for building predictive hazard models.

More Related Videos

Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay
06:25

Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay

Published on: January 12, 2024

2.2K
Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

13.2K

Related Experiment Videos

Last Updated: Feb 18, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.7K
Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay
06:25

Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay

Published on: January 12, 2024

2.2K
Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

13.2K

Area of Science:

  • Toxicology
  • Data Science
  • Computational Chemistry

Background:

  • Pharmaceutical companies have generated extensive in vivo repeat-dose toxicity (RDT) data for regulatory submissions over decades.
  • The eTOX project has compiled numerous RDT studies into a centralized database, creating a valuable resource.
  • High heterogeneity in experimental conditions across studies necessitates data normalization and standardization for analysis.

Purpose of the Study:

  • To describe a method for extracting comparable toxicological datasets from heterogeneous RDT studies.
  • To generate QSAR-like tables by mapping toxicological findings to specific in vivo endpoints.
  • To demonstrate the utility of the processed data for developing predictive toxicology models.

Main Methods:

  • Normalization of terminology used in original RDT reports.
  • Filtering of studies based on experimental conditions to ensure comparability.
  • Extraction of comparable toxicological profiles and mapping them to relevant in vivo endpoints.
  • Generation of QSAR-like tables suitable for predictive modeling.

Main Results:

  • A detailed strategy and associated tools for transforming raw RDT data into a usable format for modeling were developed.
  • Proof-of-concept predictive models for in vivo liver endpoints were successfully built using the generated datasets.
  • The processed data demonstrated suitability for developing hazard-predicting models.

Conclusions:

  • The described method effectively transforms heterogeneous RDT data into standardized, comparable datasets.
  • The generated QSAR-like tables are valuable for building predictive models of toxicological hazards.
  • This approach facilitates the exploitation of existing RDT data for regulatory and safety assessment purposes.